Advanced Micro- and Nano-Manufacturing Technologies : Applications in Biochemical and Biomedical Engineering |
Autore | Joshi Shrikrishna Nandkishor |
Pubbl/distr/stampa | Singapore : , : Springer Singapore Pte. Limited, , 2021 |
Descrizione fisica | 1 online resource (404 pages) |
Altri autori (Persone) | ChandraPranjal |
Collana | Materials Horizons: from Nature to Nanomaterials Ser. |
Soggetto genere / forma | Electronic books. |
ISBN | 981-16-3645-1 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910502640403321 |
Joshi Shrikrishna Nandkishor | ||
Singapore : , : Springer Singapore Pte. Limited, , 2021 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Advanced micro- and nano-manufacturing technologies : applications in biochemical and biomedical engineering / / Shrikrishna Nandkishor Joshi, Pranjal Chandra, editors |
Pubbl/distr/stampa | Singapore : , : Springer, , [2022] |
Descrizione fisica | 1 online resource (404 pages) |
Disciplina | 610.28 |
Collana | Materials Horizons |
Soggetto topico |
Biomedical engineering - Technological innovations
Nanomanufacturing Biochemical engineering - Technological innovations |
ISBN |
981-16-3644-3
981-16-3645-1 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910743368903321 |
Singapore : , : Springer, , [2022] | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Biointerface Engineering: Prospects in Medical Diagnostics and Drug Delivery / / edited by Pranjal Chandra, Lalit M. Pandey |
Edizione | [1st ed. 2020.] |
Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020 |
Descrizione fisica | 1 online resource (VIII, 254 p. 78 illus., 54 illus. in color.) |
Disciplina | 612.01583 |
Soggetto topico |
Biomedical engineering
Nanoscience Nanostructures Nanochemistry Engineering—Materials Biomedical Engineering/Biotechnology Nanoscale Science and Technology Materials Engineering Enginyeria biomèdica Materials biomèdics Interfícies biològiques |
Soggetto genere / forma | Llibres electrònics |
ISBN | 981-15-4790-4 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Chapter 1. Engineered Drug Delivery Systems: Insights of Biointerface -- Chapter 2. Tissue Engineering Strategies for Tooth and Dento-alveolar Region with Engineered Biomaterial and Stem Cells -- Chapter 3. Antifouling Peptoid Biointerfaces -- Chapter 4.Structure and Rheology of Hydrogels: Applications in Drug Delivery -- Chapter 5. Surface Engineering in Wearable Sensors for Medical Diagnostic Applications -- Chapter 6. Modulation of Physicochemical properties of Polymers for Effective Insulin Delivery Systems -- Chapter 7. Organization of Bio-molecules in Bulk and over the Nano-substrate: Perspective to the Molecular Dynamics Simulations -- Chapter 8. Medical Diagnostics Based on Electrochemical Biosensor -- Chapter 9. Nanomaterial functionalization Strategies in Bio-interface Development for Modern Diagnostic Devices -- Chapter 10. Bio-nano-Interface Engineering Strategies of AuNPs Passivation for Next-generation Biomedical Applications -- Chapter 11. Electrooptical Analysis as Sensing System for Detection and Diagnostic Bacterial Cells. |
Record Nr. | UNINA-9910416106603321 |
Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Biosensing and micro-nano devices : design aspects and implementation in food industries / / Pranjal Chandra, editor |
Pubbl/distr/stampa | Singapore : , : Springer, , [2022] |
Descrizione fisica | 1 online resource (365 pages) |
Disciplina | 664 |
Soggetto topico |
Food - Biotechnology
Nanostructured materials - Industrial applications Biosensors Biotecnologia alimentària Materials nanoestructurats |
Soggetto genere / forma | Llibres electrònics |
ISBN |
9789811683336
9789811683329 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910580139503321 |
Singapore : , : Springer, , [2022] | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
BioSensing, Theranostics, and Medical Devices : From Laboratory to Point-Of-Care Testing |
Autore | Borse Vivek |
Pubbl/distr/stampa | Singapore : , : Springer Singapore Pte. Limited, , 2022 |
Descrizione fisica | 1 online resource (380 pages) |
Altri autori (Persone) |
ChandraPranjal
SrivastavaRohit |
Soggetto genere / forma | Electronic books. |
ISBN |
9789811627828
9789811627811 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Intro -- Contents -- About the Editors -- Chapter 1: Gold Nanoclusters as Emerging Theranostic Interventions for Biomedical Applications -- 1.1 Introduction -- 1.2 Synthesis of AuNCs -- 1.3 Gold Nanoclusters as Biosensors -- 1.4 Gold Nanoclusters as Therapeutics -- 1.5 Conclusions and Future Prospects -- References -- Chapter 2: Advances in Materials, Methods, and Principles of Modern Biosensing Tools -- 2.1 Introduction -- 2.2 Materials for Biosensors -- 2.3 Principles of Biosensing -- 2.3.1 Colorimetric -- 2.3.1.1 Liquid Phase Biosensors -- 2.3.1.2 Paper Biosensors -- 2.3.1.3 Microfluidic Biosensors -- 2.3.1.4 Microfluidic Paper Analytical Devices (μPADs) -- 2.3.2 Colorimetric Assays -- 2.3.3 Chemiresistive Biosensors -- 2.3.4 Electrochemical Biosensors -- 2.3.5 Semiconductor Biosensors -- 2.4 Recent Trends of Biosensing and Device Fabrication -- 2.5 Future of Biosensing -- 2.6 Summary -- References -- Chapter 3: Evolution Towards Theranostics: Basic Principles -- 3.1 Introduction -- 3.2 Basic Principle of Theranostics in POC -- 3.2.1 Fundamental Prospects -- 3.2.2 Components -- 3.2.3 Point-of-Care Devices -- 3.3 Biological Factors Involved in Theranostic Applications -- 3.3.1 Administration of Nanoparticles -- 3.3.1.1 Passive Targeting -- 3.3.1.2 Active Targeting -- 3.3.1.3 Physical Targeting -- 3.3.2 The Journey of Nanoparticles to the Target Sites -- 3.4 Recent Advancements in Theranostics -- 3.5 Advantages of Smart Theranostics Agents Over Conventional Therapy -- 3.5.1 Localized Therapy -- 3.5.2 Multimodality -- 3.5.3 Simultaneous Diagnosis and Therapy -- 3.5.4 Multifunctionality -- 3.5.5 Real-Time Monitoring -- 3.5.6 Immune-Evasion -- 3.6 Challenges for Responsible Development -- 3.6.1 Toxicity -- 3.6.2 Stability -- 3.6.3 Commerciality -- 3.7 Future Perspective -- 3.8 Conclusion -- References.
Chapter 4: Biosensor-Based Point-of-Care Devices: Metabolites and Pulse Oximetry -- 4.1 Introduction -- 4.2 Glucose Measurement at the Point-of-Care -- 4.2.1 Methods of Measurement -- 4.2.2 Summary of Devices -- 4.2.2.1 Glucose Meters for At-Home Care -- 4.2.2.2 Glucose Meters for Clinical Care -- 4.3 Creatinine Measurement at the Point-of-Care -- 4.3.1 Methods of Measurement -- 4.3.2 Summary of Devices -- 4.4 Lipid Measurement at the Point-of-Care -- 4.4.1 Mechanisms of Measurement -- 4.4.2 Summary of Devices -- 4.5 Pulse Oximetry Measurements at the Point-of-Care -- 4.5.1 Methods of Measurement -- 4.5.2 Summary of Devices -- 4.6 Conclusion -- References -- Chapter 5: Biosensor-Based Point-of-Care Devices: Detection of Infectious Diseases and Cancer -- 5.1 Introduction -- 5.2 Pathogen Detection at the Point-of-Care -- 5.2.1 Methods of Detection -- 5.2.2 Summary of Devices -- 5.2.2.1 HIV -- 5.2.2.2 Tuberculosis -- 5.2.2.3 Malaria -- 5.2.2.4 Syphilis -- 5.2.2.5 Chlamydia and Gonorrhea -- 5.3 Cancer Detection at the Point-of-Care -- 5.3.1 Methods of Detection -- 5.3.2 Summary of Devices -- 5.3.2.1 Prostate Cancer -- 5.3.2.2 Colorectal Cancer -- 5.3.2.3 Liver Cancer -- 5.3.2.4 Bladder Cancer -- 5.4 Conclusion -- References -- Chapter 6: Non-invasive Cellular Characterization Using Bioimpedance Sensing -- 6.1 Introduction -- 6.2 Principle -- 6.2.1 Cell-Substrate Impedance -- 6.2.2 Design and Simulation of Sensor Configuration -- 6.3 Bioimpedance Sensor and Impedance Measurement -- 6.3.1 Device Fabrication -- 6.3.2 Cleaning and Surface Modification of the Sensor -- 6.3.3 Experimental Setup -- 6.3.4 Cell Culture and Cell Seeding Inside the Chip -- 6.3.5 Bioimpedance Measurement -- 6.4 Theoretical Analysis -- 6.4.1 Electrical Equivalent Model of the System -- 6.4.1.1 Estimation of Equivalent Model Parameters. 6.4.1.2 Fragmental Frequency Analysis Method to Extract the Model Parameters -- 6.4.2 Extracting the Single Cell Property from Measurement of Group of Cells -- 6.4.2.1 Maxwell´s Mixture Theory -- 6.4.2.2 Equivalent Electrical Model of Single Cell -- 6.5 Applications -- 6.5.1 Calculation of Equivalent Parameters of HeLa Cells Using Fragmental Frequency Analysis -- 6.5.1.1 Resistance of the PBS Media -- 6.5.1.2 Resistance Rexp -- 6.5.1.3 Coating Capacitance -- 6.5.1.4 Double Layer Capacitance -- 6.5.1.5 Equivalent Parameters of the HeLa Cells -- 6.5.2 Extraction of Single Cell Parameters of HeLa Cells -- 6.6 Summary -- References -- Chapter 7: Research Aspects and Strategies for the Development of Biosensors for Renal Disease Diagnosis -- 7.1 Point-of-Care Devices and their Importance in Renal Diseases Diagnosis -- 7.2 Various Biomarkers for Kidney Disease Diagnosis -- 7.3 Point-of-Care Devices for Kidney Injury Diagnosis -- 7.4 New Avenues in Developing POC for Renal Diseases -- 7.5 Conclusion -- References -- Chapter 8: From Natural to Artificial Biorecognition Elements: From Antibodies to Molecularly Imprinted Polymers -- 8.1 Introduction -- 8.2 Development and Production of Recognition Elements -- 8.2.1 Antibodies -- 8.2.2 APTAMERs -- 8.2.3 Molecularly Imprinted Polymers (MIPs) -- 8.3 Conclusions -- References -- Chapter 9: Design and Development of a Bed-Side Cardiac Health Monitoring Device -- 9.1 Introduction -- 9.1.1 Tissue as a Conductor -- 9.2 Evolution of Bio-Impedance: Impedance Cardiography -- 9.3 Significance of Non-Invasive Recording of Cardiac Parameters -- 9.4 Physiological and Clinical Applications of Impedance Cardiography -- 9.5 Designing an Electrode - Skin Model for Simulation Studies -- 9.5.1 Current Density -- 9.5.2 Resistive Loss -- 9.5.3 Electric Field Displacement -- 9.6 ICG Acquisition -- 9.6.1 Frequency and Current Values. 9.6.2 ICG Measurement Methods -- 9.7 ICG Device Fabrication -- 9.8 Conclusion -- References -- Chapter 10: Tailoring Multi-Functional 1D or 2D Nanomaterials: An Approach towards Engineering Futuristic Ultrasensitive Platf... -- 10.1 Introduction -- 10.2 1D or 2D Nanomaterials and its Sensing Application -- 10.2.1 1D Nanomaterials -- 10.2.1.1 Nanofibers -- 10.2.1.2 Nanowires -- 10.2.1.3 Nanotubes -- 10.2.1.4 Nanorods -- 10.2.2 2D Nanomaterials -- 10.2.2.1 Graphene -- 10.2.2.2 Transition Metal Dichalcogenides -- 10.3 Functionalization Routes towards Microbial Detection -- 10.4 1D or 2D Nanomaterials in Nano/Micro-Gap Based Sensing Devices -- 10.4.1 Planar Gaps -- 10.4.2 Planar Gap Based FET Devices -- 10.4.3 Vertical Gap -- 10.5 Sample Preparation -- 10.5.1 Cultures -- 10.5.2 Tissues -- 10.5.3 Blood/Serum/Plasma -- 10.6 Extraction of Biological Molecules for Molecular Detection -- 10.6.1 Nucleic Acid Extraction -- 10.6.2 Protein Extraction -- 10.6.3 Automated Nucleic Acid Extraction Methods -- 10.7 Fluid Kinetics for Detection Systems -- 10.8 1D or 2D Material Based Optical Detection of Microbial Strains -- 10.8.1 Fluorescent Biosensor -- 10.8.2 FRET-Based Biosensors -- 10.8.3 Raman Based Sensor -- 10.8.4 DNA Based Sensor -- 10.9 Summary and Future Work -- References -- Chapter 11: Clinical Validation of the Medical Devices: A General Prospective -- 11.1 Introduction -- 11.2 What Is Clinical Evaluation? -- 11.2.1 Definition -- 11.2.2 Pre-Clinical Evaluation -- 11.3 Needs of Clinical Evaluation of Medical Devices -- 11.4 Type of Clinical Evaluation -- 11.4.1 Clinical Investigation -- 11.4.2 By Literature Way -- 11.5 Clinical Validation According to the Type of Devices -- 11.5.1 Clinical Validation -- 11.5.2 Process Validation -- 11.5.3 Revalidation -- 11.5.4 Design Validation -- 11.6 Clinical Validation for each Class of Medical Devices. 11.7 Clinical and Analytical Validations of Biosensors Based IVDs -- 11.8 The Regulatory Perspective of the Medical Device in Consideration with Clinical Validation -- 11.8.1 Medical Device Rules (MDR)-2017, India -- 11.8.2 Food and Drug Administration USA -- 11.8.3 Medical Devices Clinical Validation Process in EU -- 11.8.4 Clinical Confirmatory Process in Australia -- 11.8.5 Medical Devices Clinical Validation in China -- 11.9 Conclusions -- References -- Chapter 12: Dried Blood Patterns for Diagnosis of Non-Communicable and Infectious Diseases -- 12.1 Introduction -- 12.2 Whole Blood and its Physical Properties -- 12.3 Physics of Pattern Formation -- 12.4 Factors Affecting the Pattern Formation -- 12.5 Disease Diagnosis Using the Dried Pattern of Blood Plasma and Serum -- 12.6 Disease Diagnosis Using the Dried Pattern of Whole Blood -- 12.7 Challenges and Future Outlook -- References -- Chapter 13: Theranostics: Principles, Materials, and Technical Advancements -- 13.1 Introduction to Principles of Theranostics -- 13.2 Materials for Cancer Theranostics -- 13.2.1 Gold-Based Nanosystems -- 13.2.2 Iron Oxide-Based Nanosystems -- 13.2.3 Other Metallic Nanosystems -- 13.2.4 Carbon-Based Nanosystems -- 13.2.5 Silica-Based Nanosystems -- 13.2.6 Quantum Dots-Based Nanosystems -- 13.2.7 Polymer-Based Nanosystems -- 13.2.8 Lipid-Based Nanosystems -- 13.3 Advanced Theranostic Nanomedicine Platforms for Clinical Applications -- 13.3.1 Photodynamic and Photothermal Therapy -- 13.3.2 Imaging -- 13.3.3 Nanobiosensors -- 13.3.4 Magnetic Hyperthermia -- 13.3.5 Multimodal Image Guided Therapy -- 13.3.6 Treatment of Cardiovascular Diseases -- 13.3.7 Treatment of Central Nervous System Related Diseases -- 13.4 Commercialization and Translational Challenges of Theranostic Nanosystems -- 13.5 Conclusion -- References. Chapter 14: Nanotheranostics: Nanoparticles Applications, Perspectives, and Challenges. |
Record Nr. | UNINA-9910512165003321 |
Borse Vivek | ||
Singapore : , : Springer Singapore Pte. Limited, , 2022 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
BioSensing, theranostics, and medical devices : from laboratory to point-of-care testing / / edited by Vivek Borse, Pranjal Chandra, and Rohit Srivastava |
Pubbl/distr/stampa | Gateway East, Singapore : , : Springer, , [2022] |
Descrizione fisica | 1 online resource (380 pages) |
Disciplina | 610.284 |
Soggetto topico |
Medicine - Research
Biosensors Theranostic Nanomedicine Biosensing Techniques Nanoparticles Equipment Design Aparells i instruments mèdics |
Soggetto genere / forma | Llibres electrònics |
ISBN |
981-16-2781-9
981-16-2782-7 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Intro -- Contents -- About the Editors -- Chapter 1: Gold Nanoclusters as Emerging Theranostic Interventions for Biomedical Applications -- 1.1 Introduction -- 1.2 Synthesis of AuNCs -- 1.3 Gold Nanoclusters as Biosensors -- 1.4 Gold Nanoclusters as Therapeutics -- 1.5 Conclusions and Future Prospects -- References -- Chapter 2: Advances in Materials, Methods, and Principles of Modern Biosensing Tools -- 2.1 Introduction -- 2.2 Materials for Biosensors -- 2.3 Principles of Biosensing -- 2.3.1 Colorimetric -- 2.3.1.1 Liquid Phase Biosensors -- 2.3.1.2 Paper Biosensors -- 2.3.1.3 Microfluidic Biosensors -- 2.3.1.4 Microfluidic Paper Analytical Devices (μPADs) -- 2.3.2 Colorimetric Assays -- 2.3.3 Chemiresistive Biosensors -- 2.3.4 Electrochemical Biosensors -- 2.3.5 Semiconductor Biosensors -- 2.4 Recent Trends of Biosensing and Device Fabrication -- 2.5 Future of Biosensing -- 2.6 Summary -- References -- Chapter 3: Evolution Towards Theranostics: Basic Principles -- 3.1 Introduction -- 3.2 Basic Principle of Theranostics in POC -- 3.2.1 Fundamental Prospects -- 3.2.2 Components -- 3.2.3 Point-of-Care Devices -- 3.3 Biological Factors Involved in Theranostic Applications -- 3.3.1 Administration of Nanoparticles -- 3.3.1.1 Passive Targeting -- 3.3.1.2 Active Targeting -- 3.3.1.3 Physical Targeting -- 3.3.2 The Journey of Nanoparticles to the Target Sites -- 3.4 Recent Advancements in Theranostics -- 3.5 Advantages of Smart Theranostics Agents Over Conventional Therapy -- 3.5.1 Localized Therapy -- 3.5.2 Multimodality -- 3.5.3 Simultaneous Diagnosis and Therapy -- 3.5.4 Multifunctionality -- 3.5.5 Real-Time Monitoring -- 3.5.6 Immune-Evasion -- 3.6 Challenges for Responsible Development -- 3.6.1 Toxicity -- 3.6.2 Stability -- 3.6.3 Commerciality -- 3.7 Future Perspective -- 3.8 Conclusion -- References.
Chapter 4: Biosensor-Based Point-of-Care Devices: Metabolites and Pulse Oximetry -- 4.1 Introduction -- 4.2 Glucose Measurement at the Point-of-Care -- 4.2.1 Methods of Measurement -- 4.2.2 Summary of Devices -- 4.2.2.1 Glucose Meters for At-Home Care -- 4.2.2.2 Glucose Meters for Clinical Care -- 4.3 Creatinine Measurement at the Point-of-Care -- 4.3.1 Methods of Measurement -- 4.3.2 Summary of Devices -- 4.4 Lipid Measurement at the Point-of-Care -- 4.4.1 Mechanisms of Measurement -- 4.4.2 Summary of Devices -- 4.5 Pulse Oximetry Measurements at the Point-of-Care -- 4.5.1 Methods of Measurement -- 4.5.2 Summary of Devices -- 4.6 Conclusion -- References -- Chapter 5: Biosensor-Based Point-of-Care Devices: Detection of Infectious Diseases and Cancer -- 5.1 Introduction -- 5.2 Pathogen Detection at the Point-of-Care -- 5.2.1 Methods of Detection -- 5.2.2 Summary of Devices -- 5.2.2.1 HIV -- 5.2.2.2 Tuberculosis -- 5.2.2.3 Malaria -- 5.2.2.4 Syphilis -- 5.2.2.5 Chlamydia and Gonorrhea -- 5.3 Cancer Detection at the Point-of-Care -- 5.3.1 Methods of Detection -- 5.3.2 Summary of Devices -- 5.3.2.1 Prostate Cancer -- 5.3.2.2 Colorectal Cancer -- 5.3.2.3 Liver Cancer -- 5.3.2.4 Bladder Cancer -- 5.4 Conclusion -- References -- Chapter 6: Non-invasive Cellular Characterization Using Bioimpedance Sensing -- 6.1 Introduction -- 6.2 Principle -- 6.2.1 Cell-Substrate Impedance -- 6.2.2 Design and Simulation of Sensor Configuration -- 6.3 Bioimpedance Sensor and Impedance Measurement -- 6.3.1 Device Fabrication -- 6.3.2 Cleaning and Surface Modification of the Sensor -- 6.3.3 Experimental Setup -- 6.3.4 Cell Culture and Cell Seeding Inside the Chip -- 6.3.5 Bioimpedance Measurement -- 6.4 Theoretical Analysis -- 6.4.1 Electrical Equivalent Model of the System -- 6.4.1.1 Estimation of Equivalent Model Parameters. 6.4.1.2 Fragmental Frequency Analysis Method to Extract the Model Parameters -- 6.4.2 Extracting the Single Cell Property from Measurement of Group of Cells -- 6.4.2.1 Maxwell´s Mixture Theory -- 6.4.2.2 Equivalent Electrical Model of Single Cell -- 6.5 Applications -- 6.5.1 Calculation of Equivalent Parameters of HeLa Cells Using Fragmental Frequency Analysis -- 6.5.1.1 Resistance of the PBS Media -- 6.5.1.2 Resistance Rexp -- 6.5.1.3 Coating Capacitance -- 6.5.1.4 Double Layer Capacitance -- 6.5.1.5 Equivalent Parameters of the HeLa Cells -- 6.5.2 Extraction of Single Cell Parameters of HeLa Cells -- 6.6 Summary -- References -- Chapter 7: Research Aspects and Strategies for the Development of Biosensors for Renal Disease Diagnosis -- 7.1 Point-of-Care Devices and their Importance in Renal Diseases Diagnosis -- 7.2 Various Biomarkers for Kidney Disease Diagnosis -- 7.3 Point-of-Care Devices for Kidney Injury Diagnosis -- 7.4 New Avenues in Developing POC for Renal Diseases -- 7.5 Conclusion -- References -- Chapter 8: From Natural to Artificial Biorecognition Elements: From Antibodies to Molecularly Imprinted Polymers -- 8.1 Introduction -- 8.2 Development and Production of Recognition Elements -- 8.2.1 Antibodies -- 8.2.2 APTAMERs -- 8.2.3 Molecularly Imprinted Polymers (MIPs) -- 8.3 Conclusions -- References -- Chapter 9: Design and Development of a Bed-Side Cardiac Health Monitoring Device -- 9.1 Introduction -- 9.1.1 Tissue as a Conductor -- 9.2 Evolution of Bio-Impedance: Impedance Cardiography -- 9.3 Significance of Non-Invasive Recording of Cardiac Parameters -- 9.4 Physiological and Clinical Applications of Impedance Cardiography -- 9.5 Designing an Electrode - Skin Model for Simulation Studies -- 9.5.1 Current Density -- 9.5.2 Resistive Loss -- 9.5.3 Electric Field Displacement -- 9.6 ICG Acquisition -- 9.6.1 Frequency and Current Values. 9.6.2 ICG Measurement Methods -- 9.7 ICG Device Fabrication -- 9.8 Conclusion -- References -- Chapter 10: Tailoring Multi-Functional 1D or 2D Nanomaterials: An Approach towards Engineering Futuristic Ultrasensitive Platf... -- 10.1 Introduction -- 10.2 1D or 2D Nanomaterials and its Sensing Application -- 10.2.1 1D Nanomaterials -- 10.2.1.1 Nanofibers -- 10.2.1.2 Nanowires -- 10.2.1.3 Nanotubes -- 10.2.1.4 Nanorods -- 10.2.2 2D Nanomaterials -- 10.2.2.1 Graphene -- 10.2.2.2 Transition Metal Dichalcogenides -- 10.3 Functionalization Routes towards Microbial Detection -- 10.4 1D or 2D Nanomaterials in Nano/Micro-Gap Based Sensing Devices -- 10.4.1 Planar Gaps -- 10.4.2 Planar Gap Based FET Devices -- 10.4.3 Vertical Gap -- 10.5 Sample Preparation -- 10.5.1 Cultures -- 10.5.2 Tissues -- 10.5.3 Blood/Serum/Plasma -- 10.6 Extraction of Biological Molecules for Molecular Detection -- 10.6.1 Nucleic Acid Extraction -- 10.6.2 Protein Extraction -- 10.6.3 Automated Nucleic Acid Extraction Methods -- 10.7 Fluid Kinetics for Detection Systems -- 10.8 1D or 2D Material Based Optical Detection of Microbial Strains -- 10.8.1 Fluorescent Biosensor -- 10.8.2 FRET-Based Biosensors -- 10.8.3 Raman Based Sensor -- 10.8.4 DNA Based Sensor -- 10.9 Summary and Future Work -- References -- Chapter 11: Clinical Validation of the Medical Devices: A General Prospective -- 11.1 Introduction -- 11.2 What Is Clinical Evaluation? -- 11.2.1 Definition -- 11.2.2 Pre-Clinical Evaluation -- 11.3 Needs of Clinical Evaluation of Medical Devices -- 11.4 Type of Clinical Evaluation -- 11.4.1 Clinical Investigation -- 11.4.2 By Literature Way -- 11.5 Clinical Validation According to the Type of Devices -- 11.5.1 Clinical Validation -- 11.5.2 Process Validation -- 11.5.3 Revalidation -- 11.5.4 Design Validation -- 11.6 Clinical Validation for each Class of Medical Devices. 11.7 Clinical and Analytical Validations of Biosensors Based IVDs -- 11.8 The Regulatory Perspective of the Medical Device in Consideration with Clinical Validation -- 11.8.1 Medical Device Rules (MDR)-2017, India -- 11.8.2 Food and Drug Administration USA -- 11.8.3 Medical Devices Clinical Validation Process in EU -- 11.8.4 Clinical Confirmatory Process in Australia -- 11.8.5 Medical Devices Clinical Validation in China -- 11.9 Conclusions -- References -- Chapter 12: Dried Blood Patterns for Diagnosis of Non-Communicable and Infectious Diseases -- 12.1 Introduction -- 12.2 Whole Blood and its Physical Properties -- 12.3 Physics of Pattern Formation -- 12.4 Factors Affecting the Pattern Formation -- 12.5 Disease Diagnosis Using the Dried Pattern of Blood Plasma and Serum -- 12.6 Disease Diagnosis Using the Dried Pattern of Whole Blood -- 12.7 Challenges and Future Outlook -- References -- Chapter 13: Theranostics: Principles, Materials, and Technical Advancements -- 13.1 Introduction to Principles of Theranostics -- 13.2 Materials for Cancer Theranostics -- 13.2.1 Gold-Based Nanosystems -- 13.2.2 Iron Oxide-Based Nanosystems -- 13.2.3 Other Metallic Nanosystems -- 13.2.4 Carbon-Based Nanosystems -- 13.2.5 Silica-Based Nanosystems -- 13.2.6 Quantum Dots-Based Nanosystems -- 13.2.7 Polymer-Based Nanosystems -- 13.2.8 Lipid-Based Nanosystems -- 13.3 Advanced Theranostic Nanomedicine Platforms for Clinical Applications -- 13.3.1 Photodynamic and Photothermal Therapy -- 13.3.2 Imaging -- 13.3.3 Nanobiosensors -- 13.3.4 Magnetic Hyperthermia -- 13.3.5 Multimodal Image Guided Therapy -- 13.3.6 Treatment of Cardiovascular Diseases -- 13.3.7 Treatment of Central Nervous System Related Diseases -- 13.4 Commercialization and Translational Challenges of Theranostic Nanosystems -- 13.5 Conclusion -- References. Chapter 14: Nanotheranostics: Nanoparticles Applications, Perspectives, and Challenges. |
Record Nr. | UNINA-9910743257803321 |
Gateway East, Singapore : , : Springer, , [2022] | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Biosensors for Personalized Healthcare / / edited by Kuldeep Mahato, Pranjal Chandra |
Autore | Mahato Kuldeep |
Edizione | [1st ed. 2024.] |
Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 |
Descrizione fisica | 1 online resource (426 pages) |
Disciplina | 610.72 |
Altri autori (Persone) | ChandraPranjal |
Soggetto topico |
Medicine - Research
Biology - Research Molecular probes Biomedical Research Translational Research Biological Sensors and Probes |
ISBN |
9789819754731
9819754739 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Introduction to Biosensors for Personalized Health -- Non-Invasive Biomarkers for Disease Diagnosis and Health Monitoring -- Affinity-based clinical biomarkers for early disease detection -- Fundamentals, Fabrication, Engineering, and Prototyping Aspects of Bioelectronics and Biosensors for Biomedical Analysis -- Signal Amplification Strategies for Biosensing of Clinically Important Analytes.-Materials for developing electrochemical biosensing systems -- Personalized on-chip sample evaluation devices for biomedical applications: advantages, challenges and opportunities -- Nanozyme mediated biosensing -- Mechanisms for analytes biosensing -- The development process of point-of-care sensor-based detection modules for biomedical diagnoses -- Biosensors for rapid and early detection of chronic diseases -- Advances in affinity-based biosensing mechanisms for direct detection /monitoring of the biomarkers -- Sweat, interstitial fluid, and saliva based wearable devices for continuous monitoring of metabolites and biomarkers -- Implantable biosensors for personalized healthcare -- Ingestible biosensors for personalized health. |
Record Nr. | UNINA-9910906194703321 |
Mahato Kuldeep | ||
Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Diagnostic strategies for COVID-19 and other coronaviruses / / Pranjal Chandra, Sharmili Roy, editors |
Edizione | [1st ed. 2020.] |
Pubbl/distr/stampa | Singapore : , : Springer, , [2021] |
Descrizione fisica | 1 online resource (VIII, 199 p. 65 illus., 49 illus. in color.) |
Disciplina | 616.0194 |
Collana | Medical Virology from Pathogenesis to Disease Control |
Soggetto topico |
Virology
Coronaviruses - Diagnosis COVID-19 (Disease) - Diagnosis COVID-19 - diagnosis |
ISBN | 981-15-6006-4 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Chapter 1. Insights into novel coronavirus detection and COVID-19 outbreak -- Chapter 2. Immunosensing technology for rapid detection of COVID-19 in remote settings -- Chapter 3. Molecular techniques for high-speed detection of COVID-19: Present and future perspective -- Chapter 4. Current efforts in theranostic approaches for COVID-19 management -- Chapter 5. Post treatment detection and monitoring of COVID-19 -- Chapter 6. Genetic analysis, structural determination, and immune responses of COVID-19 proteins: A total diagnostic perspective -- Chapter 7. CRISPER-CAS based precise detection for COVID-19 -- Chapter 8. Miniaturized biosensors for detection of other coronona virus. |
Record Nr. | UNINA-9910431350203321 |
Singapore : , : Springer, , [2021] | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Handbook of nanobioelectrochemistry : application in devices and biomolecular sensing / / edited by Uday Pratap Azad, Pranjal Chandra |
Edizione | [1st ed. 2023.] |
Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 |
Descrizione fisica | 1 online resource (955 pages) |
Disciplina | 660.6 |
Altri autori (Persone) |
AzadUday Pratap
ChandraPranjal |
Soggetto topico |
Bioelectrochemistry
Nanobiotechnology Nanoelectromechanical systems |
ISBN | 981-19-9437-4 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Introduction to Nanobioelectrochemistry. -Nanobiomaterials, classifications, and properties -- Nanobiomaterials for Proteins, Enzymes, and Biosensors -- Nanoparticles modified Ultramicroelectrode and their electroanalytical application -- Nanobiomaterial based biosensors in infectious disease diagnosis -- Nanobiomaterials: Applications in nanomedicine and drug delivery -- Metal nanoclusters in and their composites for clinical diagnosis -- Graphitic carbon nitride in biosensing application -- Nanobiomaterials for Point-of-Care Diagnostics -- Nano-Perovskites Derived Modified Electrodes in Biomolecular Detection -- Nanobiosensors: Construction and diagnosis of diseases -- Nanopaper Based Biosensors for Point of Care Diagnosis -- Nanobiostructured materials for point-of-care diagnostics -- Organic-Inorganic Hybrid Nanomaterials in Biosensing Application -- Nanodendrite a Promising Catalytic Material for Bioanalytical Application -- NanoEnzyme Based Electrodes in Biomolecular Screening and Analysis -- Nanobioelectrochemical Systems in Clinical Diagnosis -- Nanoelectrodes and Nanopores Ensembles for Electrobioanalytical Applications -- Nanomaterial Based Electrochemical Impedance Spectroscopy (EIS): principles and biosensing applications -- Micro-nano structured materials for DNA/RNA amplification-based electrochemical tests. |
Record Nr. | UNINA-9910743684403321 |
Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Immunodiagnostic technologies from laboratory to point-of-care testing / / Pankaj Suman, Pranjal Chandra, editors |
Edizione | [1st ed. 2021.] |
Pubbl/distr/stampa | Singapore : , : Springer, , [2021] |
Descrizione fisica | 1 online resource (VIII, 245 p. 64 illus., 60 illus. in color.) |
Disciplina | 616.0756 |
Soggetto topico |
Immunodiagnosis
Biomedical engineering |
ISBN | 981-15-5823-X |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Chapter 1. Timeline of the evolution of immunodiagnostics -- Chapter 2. Receptors in immunodiagnostics: Antibody and their derivatives -- Chapter 3. Engineering antibodies for biointerfacing -- Chapter 4. Alternative analyte-binding compounds for immunosensor applications -- Chapter 5. Principles and applications of immunodiagnostics using radioisotopes as tracers -- Chapter 6. Advancements and application of optical detection system in deleveopment of optical sensors -- Chapter 7. Miniaturized technologies in immunodiagnostics -- Chapter 8. Prospects of Point of care diagnostics for medical applications -- Chapter 9. Potential and advancements in namomaterial for diagnostic applications -- Chapter 10. Photoelectrochemical immunosensor in clinical diagnosis -- Chapter 11. Mutiplexing in immunodiagnosis -- Chapter 12. Biosensors for clinical samples: Considerastion and approaches -- Chapter 13. Application of immunodiagnostics in diagnosis of animal diseases -- Chapter 14. Changing trends in medical diagnosis and health monitoring with advancements in immunosensing technologies -- Chapter 15. Future perspective of immunodiagnostics in clinical applications -- Chapter 16. Commercial aspects of immunoasensors and immuoassays: Short-cominmg and future aspects. |
Record Nr. | UNINA-9910483311503321 |
Singapore : , : Springer, , [2021] | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|